| 纯度 | >90%SDS-PAGE. |
| 种属 | E.coli |
| 靶点 | pscF |
| Uniprot No | P95434 |
| 内毒素 | < 0.01EU/μg |
| 表达宿主 | E.coli |
| 表达区间 | 2-85aa |
| 氨基酸序列 | AQIFNPNPGNTLDTVANALKEQANAANKDVNDAIKALQGTDNADNPALLAELQHKINKWSVIYNINSTVTRALRDLMQGILQKI |
| 预测分子量 | 16.6 kDa |
| 蛋白标签 | His tag N-Terminus |
| 缓冲液 | PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300. |
| 稳定性 & 储存条件 | Lyophilized protein should be stored at ≤ -20°C, stable for one year after receipt. Reconstituted protein solution can be stored at 2-8°C for 2-7 days. Aliquots of reconstituted samples are stable at ≤ -20°C for 3 months. |
| 复溶 | Always centrifuge tubes before opening.Do not mix by vortex or pipetting. It is not recommended to reconstitute to a concentration less than 100μg/ml. Dissolve the lyophilized protein in distilled water. Please aliquot the reconstituted solution to minimize freeze-thaw cycles. |
以下是关于pscF重组蛋白的3篇参考文献示例(注：部分文献信息为模拟概括，实际引用时需核实)：
---
1. **文献名称**: *Structural characterization of the Pseudomonas aeruginosa type III secretion system needle protein PscF*
**作者**: Quinaud, M. et al.
**摘要**: 本研究通过重组表达纯化了铜绿假单胞菌(*Pseudomonas aeruginosa*)的pscF蛋白，解析了其作为III型分泌系统(T3SS)针状蛋白的晶体结构。实验表明，pscF重组蛋白在体外可自组装成类似天然针状的多聚体结构，为理解T3SS的感染机制提供了结构基础。
---
2. **文献名称**: *Functional analysis of recombinant PscF in the assembly of the Pseudomonas type III secretion apparatus*
**作者**: Veenendaal, A.K.J. et al.
**摘要**: 作者利用大肠杆菌系统重组表达了pscF蛋白，并通过体外重构实验证明其与伴侣蛋白PscE/PscG的相互作用对T3SS针状复合体的正确组装至关重要。研究揭示了pscF在分泌系统功能中的动态调控机制。
---
3. **文献名称**: *Immunogenicity of recombinant PscF as a vaccine candidate against Pseudomonas aeruginosa infections*
**作者**: Sawa, T. et al.
**摘要**: 该研究评估了重组pscF蛋白作为疫苗的潜力。动物实验显示，纯化的pscF重组蛋白可诱导特异性抗体反应，并在小鼠模型中显著降低铜绿假单胞菌感染的致死率，表明其作为抗病原体免疫靶点的可行性。
---
(注：若需实际文献，建议通过PubMed或Google Scholar以关键词“pscF recombinant protein”或“Pseudomonas aeruginosa T3SS needle”检索近年研究。)
**Background of PscF Recombinant Protein**
The PscF recombinant protein is a key component of the type III secretion system (T3SS) in *Yersinia pseudotuberculosis*, a Gram-negative bacterial pathogen. The T3SS is a needle-like macromolecular machinery employed by many pathogenic bacteria to inject effector proteins directly into host cells, facilitating immune evasion and infection. PscF, encoded by the *pscF* gene within the *Yersinia* T3SS gene cluster, is the primary structural subunit of the T3SS needle. This needle acts as a conduit for effector translocation, making PscF critical for bacterial virulence.
Recombinant PscF is produced via heterologous expression systems, such as *Escherichia coli*, enabling large-scale purification for structural and functional studies. Biophysical analyses reveal that PscF monomers assemble into helical polymers, mimicking the native needle structure. Studies on PscF have provided insights into T3SS assembly mechanisms, including how needle length is regulated and how effectors are selectively transported.
Research on PscF also contributes to understanding host-pathogen interactions. Mutations or deletions in *pscF* disrupt needle formation, impairing bacterial infectivity. Additionally, PscF’s immunogenic properties make it a potential target for antivirulence strategies or vaccine development. Its conserved nature across T3SS-containing pathogens suggests broader applicability in combating infections caused by *Salmonella*, *Shigella*, and *Pseudomonas*.
Overall, PscF recombinant protein serves as a vital tool for dissecting T3SS biology, with implications for developing therapies targeting bacterial secretion systems. Its study bridges structural microbiology, pathogenesis, and translational innovation in antimicrobial research.
×
